{
    "2020-06-12": [
        [
            {
                "time": "2023-10-05",
                "original_text": "AbbVie Recommends Shareholders Reject TRC Capital's &quot;Mini-Tender&quot; Offer",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Shareholders",
                        "Reject",
                        "TRC",
                        "Mini-Tender"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie Presents New Late-Breaking Data Showing SKYRIZI® Achieves Superior Rates of Complete Skin Clearance Versus COSENTYX® at 52 Weeks",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "SKYRIZI",
                        "COSENTYX",
                        "Superior",
                        "Data"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "The Zacks Analyst Blog Highlights: AbbVie, Eagle Bancorp Montana, H&R Block, Mackinac Financial and Virtu Financial",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "AbbVie",
                        "Eagle Bancorp",
                        "H&R Block",
                        "Mackinac Financial",
                        "Virtu Financial"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "5 Defensive Stocks to Buy as Coronavirus Cases Rise Again",
                "features": {
                    "keywords": [
                        "Defensive",
                        "Stocks",
                        "Coronavirus",
                        "Cases",
                        "Rise"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "defensive stocks"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Pharma Stock Roundup: Coronavirus Updates From ABBV, LLY, JNJ, FDA Approvals",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "Roundup",
                        "Coronavirus",
                        "Updates",
                        "ABBV",
                        "LLY",
                        "JNJ",
                        "FDA",
                        "Approvals"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "COVID-19 cases surge, officials issue warnings",
                "features": {
                    "keywords": [
                        "COVID-19",
                        "cases",
                        "surge",
                        "officials",
                        "warnings"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "public health"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Go Defensive to Beat Market Turbulence With These 4 Stocks",
                "features": {
                    "keywords": [
                        "Defensive",
                        "Market",
                        "Turbulence",
                        "Stocks"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "defensive stocks"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie Jumped Into The Coronavirus Drug Hunt — Is AbbVie Stock A Buy?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Coronavirus",
                        "Drug",
                        "Hunt",
                        "Buy"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}